# A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

> **NCT05508568** · — · UNKNOWN · sponsor: **Arquer Diagnostics Ltd** · enrollment: 650 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DIAGNOSTIC_TEST:** ADXBLADDER

## Key facts

- **NCT ID:** NCT05508568
- **Lead sponsor:** Arquer Diagnostics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-04
- **Target enrollment:** 650 (ESTIMATED)
- **Last updated:** 2023-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05508568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05508568, "A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05508568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*